These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9430048)

  • 1. The international consensus process on psychopharmacology and intellectual disability.
    Reiss S; Aman MG
    J Intellect Disabil Res; 1997 Dec; 41 ( Pt 6)():448-55. PubMed ID: 9430048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A guide to psychopharmacological treatment of patients with intellectual disability in psychiatry.
    Molina-Ruiz RM; Martín-Carballeda J; Asensio-Moreno I; Montañés-Rada F
    Int J Psychiatry Med; 2017 Mar; 52(2):176-189. PubMed ID: 28792289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Training psychiatric residents in the diagnosis and treatment of mental illness in mentally retarded persons.
    Menolascino FJ; Fleisher MH
    Hosp Community Psychiatry; 1992 May; 43(5):500-3. PubMed ID: 1587515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacotherapy in children and adults with intellectual disability.
    Santosh PJ; Baird G
    Lancet; 1999 Jul; 354(9174):233-42. PubMed ID: 10421318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practitioner versus medication-expert opinion on psychiatric pharmacotherapy of mentally retarded patients with mental disorders.
    Patel NC; Crismon ML; Rush AJ; Frances A
    Am J Health Syst Pharm; 2001 Oct; 58(19):1824-9. PubMed ID: 11596698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacology and mental retardation: a 10 year review (1990-1999).
    Matson JL; Bamburg JW; Mayville EA; Pinkston J; Bielecki J; Kuhn D; Smalls Y; Logan JR
    Res Dev Disabil; 2000; 21(4):263-96. PubMed ID: 10983783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacology research for individuals with mental retardation: methodological issues and suggestions.
    Matson JL; Bielecki J; Mayville SB; Matson ML
    Res Dev Disabil; 2003; 24(3):149-57. PubMed ID: 12742384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Professionals' perceptions of psychotropic medication in residential facilities for individuals with mental retardation.
    Singh NN; Ellis CR; Donatelli LS; Williams DE; Ricketts RW; Goza AB; Perlman N; Everly DE; Best AM; Singh YN
    J Intellect Disabil Res; 1996 Feb; 40 ( Pt 1)():1-7. PubMed ID: 8930051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed consent for medication in persons with mental retardation and mental illness.
    O'Sullivan JL; Borcherding BG
    Health Matrix Clevel; 2002; 12(1):63-92. PubMed ID: 12013701
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychotropic prescribing in people with intellectual disability and challenging behaviour.
    Sheehan R; Strydom A; Morant N; Pappa E; Hassiotis A
    BMJ; 2017 Aug; 358():j3896. PubMed ID: 28821479
    [No Abstract]   [Full Text] [Related]  

  • 12. Toward Actionable Practice Parameters for "Dual Diagnosis": Principles of Assessment and Management for Co-Occurring Psychiatric and Intellectual/Developmental Disability.
    Constantino JN; Strom S; Bunis M; Nadler C; Rodgers T; LePage J; Cahalan C; Stockreef A; Evans L; Jones R; Wilson A
    Curr Psychiatry Rep; 2020 Feb; 22(2):9. PubMed ID: 32008108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacological issues in treating psychiatric disorders of patients with mental retardation.
    Arnold LE
    Ann Clin Psychiatry; 1993 Sep; 5(3):189-97. PubMed ID: 8281242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why some drugs work and others do not.
    Kramer TA
    MedGenMed; 2003 May; 5(2):25. PubMed ID: 14603124
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of psychotropic medications for persons with mental retardation who live in Oklahoma nursing homes.
    Spreat S; Conroy J
    Psychiatr Serv; 1998 Apr; 49(4):510-2. PubMed ID: 9550242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
    Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
    Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric and behavioural disorders amongst older severely mentally handicapped inpatients.
    James DH
    J Ment Defic Res; 1986 Dec; 30 ( Pt 4)():341-5. PubMed ID: 3806661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic drug prescribing in child and adolescent learning disability psychiatry.
    Bramble D
    J Psychopharmacol; 2007 Jul; 21(5):486-91. PubMed ID: 17446203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mental disorders and problematic behaviours in people with intellectual disability: future directions for research.
    Moss S; Emerson E; Bouras N; Holland A
    J Intellect Disabil Res; 1997 Dec; 41 ( Pt 6)():440-7. PubMed ID: 9430047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
    Perry BI; Cooray SE; Mendis J; Purandare K; Wijeratne A; Manjubhashini S; Dasari M; Esan F; Gunaratna I; Naseem RA; Hoare S; Chester V; Roy A; Devapriam J; Alexander R; Kwok HF
    J Intellect Disabil Res; 2018 Feb; 62(2):140-149. PubMed ID: 29349928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.